Chitosan-based drug delivery systems

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 81, Issue 3, 2012, Pages 463-469

  Bernkop Schnürch, Andreas ^a   Dünnhaupt, Sarah ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Chitosan; Controlled release; Drug delivery; Mucoadhesion; Permeation enhancement

Indexed keywords

ALGINIC ACID; AMINE; CARBOMER; CARBOXYMETHYLCELLULOSE; CARRAGEENAN; CHITOSAN; CYCLOSPORIN A; DODECYL SULFATE SODIUM; EXCIPIENT; GANCICLOVIR; HYALURONIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; INSULIN; LIPOFECTAMINE; NANOPARTICLE; NAPROXEN; PECTIN; PLASMID DNA; POLYACRYLIC ACID; POLYARGININE; POLYCAPROLACTONE; POLYCARBOPHIL; POLYETHYLENEIMINE; POLYLYSINE; RHODAMINE 123; SMALL INTERFERING RNA; TECHNETIUM 99M; THIOCTIC ACID; THIOGLYCOLIC ACID; UNINDEXED DRUG;

CHEMICAL MODIFICATION; CONTROLLED DRUG RELEASE; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG PENETRATION; ENDOCYTOSIS; GELATION; HUMAN; HYDROGEL; MOLECULAR WEIGHT; MUCOADHESION; NONHUMAN; PARTICLE SIZE; PH; PHASE TRANSITION; REVIEW; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; VISCOSITY;

ANIMALS; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; PERMEABILITY; PHARMACEUTICAL PREPARATIONS;

EID: 84863786018     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.04.007     Document Type: Review

References (78)

1. K. Bhise, R. Dhumal, A. Paradkar, S. Kadam, Effect of drying methods on swelling, erosion and drug release from chitosan-naproxen sodium complexes, AAPS PharmSciTech 9 (2008) 1-12.
2. W. Sun, S. Mao, Y. Wang, V.B. Junyaprasert, T. Zhang, L. Na, J. Wang, Bioadhesion and oral absorption of enoxaparin nanocomplexes, Int. J. Pharm. 386 (2010) 275-281.
3. C. Tapia, V. Corbalán, E. Costa, M.N. Gai, M. Yazdani-Pedram, Study of the release mechanism of diltiazem hydrochloride from matrices based on chitosan-alginate and chitosan-carrageenan mixtures, Biomacromolecules 6 (2005) 2389-2395. (Pubitemid 41388248)
4. G. Shavi, U. Nayak, M. Reddy, A. Karthik, P. Deshpande, A. Kumar, N. Udupa, Sustained release optimized formulation of anastrozole-loaded chitosan microspheres: in vitro and in vivo evaluation, J. Mater. Sci. Mater. Med. 22 (2011) 865-878.
5. V. Grabovac, D. Guggi, A. Bernkop-Schnürch, Comparison of the mucoadhesive properties of various polymers, Adv. Drug Deliv. Rev. 57 (2005) 1713-1723. (Pubitemid 41443475)
6. H.L. Lueßen, B.J. de Leeuw, M.W.E. Langemeÿer, A.G. de Boer, J.C. Verhoef, H.E. Junginger, Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo, Pharm. Res. 13 (1996) 1668-1672. (Pubitemid 26426890)
7. A. Jintapattanakit, V.B. Junyaprasert, T. Kissel, The role of mucoadhesion of trimethyl chitosan and PEGylated trimethyl chitosan nanocomplexes in insulin uptake, J. Pharm. Sci. 98 (2009) 4818-4830.
8. M. Werle, A. Bernkop-Schnürch, Thiolated chitosans: useful excipients for oral drug delivery, J. Pharm. Pharmacol. 60 (2008) 273-281. (Pubitemid 351269813)
9. S. Gupta, S.P. Vyas, Carbopol/chitosan based pH triggered in situ gelling system for ocular delivery of timolol maleate, Sci. Pharm. 78 (2010) 959-976.
10. D. Sakloetsakun, J. Hombach, A. Bernkop-Schnürch, In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agents, Biomaterials 30 (2009) 6151-6157.
11. S. Mao, W. Sun, T. Kissel, Chitosan-based formulations for delivery of DNA and siRNA, Adv. Drug Deliv. Rev. 62 (2010) 12-27.
12. H. Yu, X. Chen, T. Lu, J. Sun, H. Tian, J. Hu, Y. Wang, P. Zhang, X. Jing, Poly(L-lysine)-graft-chitosan copolymers: synthesis, characterization, and gene transfection effect, Biomacromolecules 8 (2007) 1425-1435. (Pubitemid 46865113)
13. D. Lee, S.S. Mohapatra, Chitosan nanoparticle-mediated gene transfer, in: J.M. Doux (Ed.), Gene Therapy Protocols, Humana Press, 2008, pp. 127-140.
14. J. Malmo, K.M. Vrum, S.P. Strand, Effect of chitosan chain architecture on gene delivery: comparison of self-branched and linear chitosans, Biomacromolecules 12 (2011) 721-729.
15. R. Martien, B. Loretz, M. Thaler, S. Majzoob, A. Bernkop-Schnürch, Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?, J Biomed. Mater. Res. A 82 (2007) 1-9. (Pubitemid 46906486)
16. A.K. Varkouhi, R.J. Verheul, R.M. Schiffelers, T. Lammers, G. Storm, W.E. Hennink, Gene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosan, Bioconjugate Chem. 21 (2010) 2339-2346.
17. D. Teijeiro-Osorio, C. Remuñán-López, M.J. Alonso, Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro, Eur. J. Pharm. Biopharm. 71 (2009) 257-263.
18. M. Malhotra, C. Lane, C. Tomaro-Duchesneau, S. Saha, S. Prakash, A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis, Int. J. Nanomed. 6 (2011) 485-494.
19. N.G.M. Schipper, S. Olsson, J.A. Hoogstraate, A.G. deBoer, K.M. Vårum, P. Artursson, Chitosans as absorption enhancers for poorly absorbable drugs. 2: Mechanism of absorption enhancement, Pharm. Res. 14 (1997) 923-929. (Pubitemid 27326989)
20. A.F. Kotzé, H.L. Lueßen, B.J. de Leeuw, B.G. de Boer, J. Coos Verhoef, H.E. Junginger, Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2), J. Control. Release 51 (1998) 35-46. (Pubitemid 28064643)
21. N.G.M. Schipper, K.M. Vårum, P. Artursson, Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (caco-2) cells, Pharm. Res. 13 (1996) 1686-1692. (Pubitemid 26426893)
22. C.E. Kast, A. Bernkop-Schnürch, Influence of the molecular mass on the permeation enhancing effect of different poly(acrylates), STP Pharm. Sci. 6 (2002) 351-356. (Pubitemid 35407909)
23. P. Shah, V. Jogani, P. Mishra, A.K. Mishra, T. Bagchi, A. Misra, Modulation of ganciclovir intestinal absorption in presence of absorption enhancers, J. Pharm. Sci. 96 (2007) 2710-2722. (Pubitemid 47597820)
24. A. Trapani, A. Lopedota, M. Franco, N. Cioffi, E. Ieva, M. Garcia-Fuentes, M.J. Alonso, A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides, Eur. J. Pharm. Biopharm. 75 (2010) 26-32.
25. N. Langoth, H. Kahlbacher, G. Schöffmann, I. Schmerold, M. Schuh, S. Franz, P. Kurka, A. Bernkop-Schnürch, Thiolated chitosans: design and in vivo evaluation of a mucoadhesive buccal peptide drug delivery system, Pharm. Res. 23 (2006) 573-579.
26. N. Langoth, A. Bernkop-Schnürch, P. Kurka, In vitro evaluation of various buccal permeation enhancing systems for PACAP (pituitary adenylate cyclase-activating polypeptide), Pharm. Res. 22 (2005) 2045-2050. (Pubitemid 41821583)
27. B.B. Carreno-Gomez, R.W. Duncan, Compositions with Enhanced oral Bioavailability, US Patent 20030211072, 2003.
28. F. Föger, T. Schmitz, A. Bernkop-Schnürch, In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan, Biomaterials 27 (2006) 4250-4255.
29. T.F. Palmberger, J. Hombach, A. Bernkop-Schnürch, Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir, Int. J. Pharm. 348 (2008) 54-60. (Pubitemid 350266239)
30. G.S. Macleod, J.T. Fell, J.H. Collett, H.L. Sharma, A.-M. Smith, Selective drug delivery to the colon using pectin:chitosan:hydroxypropyl methylcellulose film coated tablets, Int. J. Pharm. 187 (1999) 251-257. (Pubitemid 29443905)
31. A. Bernkop-Schnürch, E. Reich-Rohrwig, M. Marschütz, H. Schuhbauer, M. Kratzel, Development of a sustained release dosage form for α-lipoic acid. II. Evaluation in human volunteers, Drug Dev. Ind. Pharm. 30 (2004) 35-42. (Pubitemid 38240474)
32. P. Mura, N. Zerrouk, N. Mennini, F. Maestrelli, C. Chemtob, Development and characterization of naproxen-chitosan solid systems with improved drug dissolution properties, Eur. J. Pharm. Sci. 19 (2003) 67-75. (Pubitemid 36506939)
33. C. Kose-Ozkan, A. Savaser, C. Tas, Y. Ozkan, The development and in vitro evaluation of sustained release tablet formulations of benzydamine hydrochloride and its determination, Comb. Chem. High Throughput Screening 13 (2010) 683-689.
34. S. Mutalik, K. Manoj, M. Reddy, P. Kushtagi, A. Usha, P. Anju, A. Ranjith, N. Udupa, Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies, AAPS PharmSciTech 9 (2008) 651-659.
35. S. Dhaliwal, S. Jain, H. Singh, A. Tiwary, Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation, AAPS J. 10 (2008) 322-330.
36. Y. Akiyama, N. Nagahara, E. Nara, M. Kitano, S. Iwasa, I. Yamamoto, J. Azuma, Y. Ogawa, Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites, J. Pharm. Pharmacol. 50 (1998) 159-166. (Pubitemid 28102572)
37. M. Säkkinen, J. Marvola, H. Kanerva, K. Lindevall, A. Ahonen, M. Marvola, Scintigraphic verification of adherence of a chitosan formulation to the human oesophagus, Eur. J. Pharm. Biopharm. 57 (2004) 145-147. (Pubitemid 38058813)
38. A.B. Sieval, M. Thanou, A.F. Kotzé, J.C. Verhoef, J. Brussee, H.E. Junginger, Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride, Carbohydr. Polym. 36 (1998) 157-165. (Pubitemid 128399589)
39. A. Bernkop-Schnürch, M. Hornof, T. Zoidl, Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates, Int. J. Pharm. 260 (2003) 229-237. (Pubitemid 36773920)
40. K. Kafedjiiski, A.H. Krauland, M.H. Hoffer, A. Bernkop-Schnürch, Synthesis and in vitro evaluation of a novel thiolated chitosan, Biomaterials 26 (2005) 819-826. (Pubitemid 39179966)
41. M. Thanou, B.I. Florea, M.W.E. Langemeÿer, J.C. Verhoef, H.E. Junginger, N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (caco-2 cells) and in vivo (rats), Pharm. Res. 17 (2000) 27-31. (Pubitemid 30121095)
42. B. Sarmento, A. Ribeiro, F. Veiga, P. Sampaio, R. Neufeld, D. Ferreira, Alginate/chitosan nanoparticles are effective for oral insulin delivery, Pharm. Res. 24 (2007) 2198-2206. (Pubitemid 350060707)
43. H. Gupta, T. Velpandian, S. Jain, Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery, J. Drug Targeting 18 (2010) 499-505.
44. A.M. De Campos, A. Sánchez, M.a.J. Alonso, Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A, Int. J. Pharm. 224 (2001) 159-168. (Pubitemid 32706495)
45. P. Calvo, J.L. Vila-Jato, M.a.J. Alonso, Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers, Int. J. Pharm. 153 (1997) 41-50. (Pubitemid 27283332)
46. A.M. De Campos, A. Sánchez, M.J. Alonso, Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A, Int. J. Pharm. 224 (2001) 159-168. (Pubitemid 32706495)
47. I. Genta, B. Conti, P. Perugini, F. Pavanetto, A. Spadaro, G. Puglisi, Bioadhesive microspheres for ophthalmic administration of acyclovir, J. Pharm. Pharmacol. 49 (1997) 737-742. (Pubitemid 27386891)
48. L. Illum, Nasal drug delivery - possibilities, problems and solutions, J. Control. Release 87 (2003) 187-198. (Pubitemid 36255456)
49. R.J. Soane, M. Frier, A.C. Perkins, N.S. Jones, S.S. Davis, L. Illum, Evaluation of the clearance characteristics of bioadhesive systems in humans, Int. J. Pharm. 178 (1999) 55-65. (Pubitemid 29074407)
50. L. Ilium, Chitosan and its use as a pharmaceutical excipient, Pharm. Res. 15 (1998) 1326-1331.
51. L. Na, S. Mao, J. Wang, W. Sun, Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats, Int. J. Pharm. 397 (2010) 59-66.
52. D. Teijeiro-Osorio, C. Remuñán-López, M. José Alonso, New generation of hybrid poly oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules, Biomacromolecules 10 (2008) 243-249.
53. X. Zhang, H. Zhang, Z. Wu, Z. Wang, H. Niu, C. Li, Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles, Eur. J. Pharm. Biopharm. 68 (2008) 526-534. (Pubitemid 351318209)
54. R. Fernández-Urrusuno, P. Calvo, C. Remuñán- López, J.L. Vila-Jato, M. JoséAlonso, Enhancement of nasal absorption of insulin using chitosan nanoparticles, Pharm. Res. 16 (1999) 1576-1581. (Pubitemid 29510555)
55. A. Fisher, M. Watling, A. Smith, A. Knight, Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188, Int. J. Clin. Pharmacol. Ther. 48 (2010) 138-145.
56. A. El-Kamel, M. Sokar, V. Naggar, S. Al Gamal, Chitosan and sodium alginate-based bioadhesive vaginal tablets, AAPS J. 4 (2002) 224-230.
57. G. Sandri, S. Rossi, F. Ferrari, M.C. Bonferoni, C. Muzzarelli, C. Caramella, Assessment of chitosan derivatives as buccal and vaginal penetration enhancers, Eur. J. Pharm. Sci. 21 (2004) 351-359. (Pubitemid 38156173)
58. D. Raafat, H.-G. Sahl, Chitosan and its antimicrobial potential - a critical literature survey, Microb. Biotechnol. 2 (2009) 186-201.
59. K. Aiedeh, M.O. Taha, Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral theophylline sustained-release beads, Eur. J. Pharm. Sci. 13 (2001) 159-168. (Pubitemid 32288785)
60. G. Sandri, S. Rossi, M.C. Bonferoni, F. Ferrari, Y. Zambito, G. Di Colo, C. Caramella, Buccal penetration enhancement properties of N-trimethyl chitosan: influence of quaternization degree on absorption of a high molecular weight molecule, Int. J. Pharm. 297 (2005) 146-155. (Pubitemid 40720274)
61. S.M. Upadrashta, P.R. Katikaneni, N.O. Nuessle, Chitosan as a tablet binder, Drug Dev. Ind. Pharm. 18 (1992) 1701-1708.
62. S.W. Richardson, H.J. Kolbe, R. Duncan, Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA, Int. J. Pharm. 178 (1999) 231-243. (Pubitemid 29078577)
63. C.G. Pitt, The controlled parenteral delivery of polypeptides and proteins, Int. J. Pharm. 59 (1990) 173-196. (Pubitemid 20146149)
64. B.C. Thanoo, M.C. Sunny, A. Jayakrishnan, Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals, J. Pharm. Pharmacol. 44 (1992) 283-286.
65. R.J. Nordtveit, K.M. Vårum, O. Smidsrød, Degradation of fully water-soluble, partially N-acetylated chitosans with lysozyme, Carbohydr. Polym. 23 (1994) 253-260.
66. H. Onishi, Y. Machida, K. Kamiyama, Pharmacokinetics and tissue distribution properties of glycol-chitosan and N-succinyl-chitosan in mice, in: Proceedings of the Controlled Release Society, 1996, pp. 645-646.
67. J.-H. Kim, Y.-S. Kim, K. Park, E. Kang, S. Lee, H.Y. Nam, K. Kim, J.H. Park, D.Y. Chi, R.-W. Park, I.-S. Kim, K. Choi, I. Chan Kwon, Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy, Biomaterials 29 (2008) 1920-1930.
68. J. Barthelmes, G. Perera, J. Hombach, S. Dünnhaupt, A. Bernkop-Schnürch, Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder, Int. J. Pharm. 416 (2011) 339-345.
69. M. Maeda, H. Murakami, H. Ohta, M. Tajima, Stimulation of IgM production in human-human hybridoma HB4C5 cells by chitosan, Biosci., Biotechnol., Biochem. 56 (1992) 427-431.
70. I. Jabbal-Gill, A.N. Fisher, R. Rappuoli, S.S. Davis, L. Illum, Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice, Vaccine 16 (1998) 2039-2046. (Pubitemid 28473954)
71. R. Garmise, H. Staats, A. Hickey, Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination, AAPS PharmSciTech 8 (2007) 2-10.
72. R.C. Read, S.C. Naylor, C.W. Potter, J. Bond, I. Jabbal-Gill, A. Fisher, L. Illum, R. Jennings, Effective nasal influenza vaccine delivery using chitosan, Vaccine 23 (2005) 4367-4374. (Pubitemid 40991223)
73. A. Bacon, J. Makin, P.J. Sizer, I. Jabbal-Gill, M. Hinchcliffe, L. Illum, S. Chatfield, M. Roberts, Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens, Infect. Immun. 68 (2000) 5764-5770.
74. I.M. van der Lubben, J.C. Verhoef, A.C. van Aelst, G. Borchard, H.E. Junginger, Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches, Biomaterials 22 (2001) 687-694. (Pubitemid 32112293)
75. A. Vila, A. Sánchez, K. Janes, I. Behrens, T. Kissel, J.L.V. Jato, M.J. Alonso, Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice, Eur. J. Pharm. Biopharm. 57 (2004) 123-131. (Pubitemid 38058811)
76. O. Borges, A. Cordeiro-da-Silva, J. Tavares, N. Santarém, A. de Sousa, G. Borchard, H.E. Junginger, Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles, Eur. J. Pharm. Biopharm. 69 (2008) 405-416.
77. S.M. Bal, B. Slütter, R. Verheul, J.A. Bouwstra, W. Jiskoot, Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice, Eur. J. Pharm. Sci. 45 (2012) 475-481.
78. B. Slütter, L. Plapied, V. Fievez, M. Alonso Sande, A. des Rieux, Y.-J. Schneider, E. Van Riet, W. Jiskoot, V. Préat, Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination, J. Control. Release 138 (2009) 113-121.